Wednesday, October 12, 2005
Genentech profits surge on drug sales
SAN FRANCISCO (AP) - Genentech Inc. reported a 56 per cent surge in third-quarter net income, fuelled by strong drug sales of its newest colon cancer drug and its flagship breast cancer fighter....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment